Chargement en cours...
Clinical Effects of Exposure to DPP-4 Inhibitors as Reported to the National Poison Data System
DPP-4 inhibitors (sitagliptin, saxagliptin, and linagliptin) are approved for the treatment of diabetes. They are considered safe due to their hyperglycemia dependent mechanism of action. We examined all isolated exposures to DPP-4 inhibitors reported to the National Poison Database System since 200...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Springer US
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4057539/ https://ncbi.nlm.nih.gov/pubmed/24515526 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13181-014-0383-6 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|